Anne Erickson

Ms. Erickson has served as Savara’s Chief Business and Corporate Affairs Officer since February 2026 and is responsible for Investor Relations & Corporate Affairs, Advocacy Relations & Patient Engagement, and Savara’s Expanded Access Program. Additionally, she leads Facilities and IT Operations for the company as well as corporate strategy projects. Since joining Savara in October 2018, Ms. Erickson has taken on roles of increasing responsibility, including Chief Business Officer, SVP of Global Business Operations, and Chief of Staff. She was responsible for the Clinical Operations team from study start-up through the double-blind period of the Phase 3 IMPALA-2 clinical trial and served as Interim Head of Quality Assurance. She has also previously overseen Medical Affairs and Project Management for the company. Before joining Savara, Ms. Erickson held senior leadership roles within corporate, consulting, and agency environments at organizations including Mirati Therapeutics, Halozyme, Pfizer, and Ogilvy.